Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

By M. Bertrand, M. Simoons, K. Fox, L. Wallentin, C. Hamm, E. Mcfadden, P. D. de Feyter, G. Specchia, W. Rużyłło. European Heart Journal, 2002

852 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. (2005, background): “Dofetilide is a new drug with promising results in medical cardioversion and prevention of new AF, but further studies are needed to evaluate its safety and efficacy in AHF.193 b-blocking agents can be tried in SVTs when tolerated.194,195 In wide complex tachycardia, intravenous adenosine can be use”
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. (2005, methodology): “GP IIb/IIIa inhibitors for PCI in NSTE-ACS The individual studies investigating GP IIb/IIIa inhibitors in patients with NSTE-ACS have been discussed in detail in the ESC NSTE-ACS guidelines.(60) With respect to PCI, the studies investigating the usefulness of GP IIb/IIIa inhibitors in NSTE-ACS can b”